Net Income Per Common Share

6 Months Ended

Jan. 31, 2012

NOTE 3 - Net Income (Loss) Per Common Share

The following table sets forth the computation of basic and diluted net income (loss) per common share:

	Three Months Ended January 31,						Six Months Ended January 31,
	2012			2011			2012		2011
Numerator:
Net income (loss)	$	(714,687	)	$	11,301,607		$	1,098,678	$	2,439,411
Denominator:
Weighted average number of common shares outstanding		49,823,330			47,323,880			49,823,330		47,320,728

Income (Loss) per common share:
Basic	$	(0.01	)	$	0.24		$	0.02	$	0.05
Diluted	$	(0.01	)	$	(0.01	)	$	0.00	$	(0.02	)
Potentially dilutive securities:
Warrants		45,833,328			11,818,180			45,833,328		49,784,000
Convertible notes (principal & interest)		24,916,667			23,043,833			24,916,667		23,043,833
Stock options		3,204,267			3,424,867			3,204,267		3,424,867
Total potentially dilutive securities		73,152,892			76,252,700			73,152,892		76,252,700

As the Company had incurred a net loss for the three months ending January 31, 2012 basic and diluted per common share amounts are the same, as the inclusion of all potentially dilutive securities would be anti-dilutive.

- Definition

The entire disclosure for earnings per share.

+ References+ Details

Tamir Biotechnology, Inc. 10-Q